Clinical Trials Logo

Clinical Trial Summary

The main objective of this study will be to assess the efficacy of natural progesterone at a daily dose of 25 mg in restoring a normal luteal phase. The primary end-point will be the ongoing pregnancy rate.

The secondary objectives will be the rate of endometrial biopsy showing an in phase endometrium after 3 months of treatment.

The length of the luteal phase of the menstrual cycle after treatment will also be assessed and compared with the initial duration (from LH peak to onset of menstruation).


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT02950948
Study type Interventional
Source IBSA Institut Biochimique SA
Contact
Status Withdrawn
Phase Phase 3
Start date May 3, 2017
Completion date December 2019

See also
  Status Clinical Trial Phase
Completed NCT01178931 - Dydrogesterone Versus Intravaginal Progesterone in the Luteal Phase Support N/A
Completed NCT04174378 - Luteal Phase Support In IVF Women Using GnRH Agonist
Completed NCT04938622 - Bioenergetics of Exercise-Induced Menstrual Disturbances N/A
Completed NCT04722471 - Progesterone Levels and Clinical Outcomes Using a Single Pessary of 400 mg of Vaginal Progesterone in Substitutive Cycles for Embryo Transfer.
Completed NCT02458404 - Effects of Varied Estrogen Doses on Endometrial Receptivity
Completed NCT05107804 - Energy Restriction and Hormones in Premenopausal Women N/A
Completed NCT03948022 - Luteal Support in Frozen-Thawed Embryo Transfer Cycles Phase 4
Not yet recruiting NCT05080569 - Luteal Phase Support in IUI MOH Treatment Luteal Phase Support in IUI MOH Treatment Phase 4
Recruiting NCT04806919 - Luteal Support in Artificial Vitrified/Warmed Cycles With Low Progesterone Phase 3